Advertisement
UK markets closed
  • FTSE 100

    8,210.07
    +37.92 (+0.46%)
     
  • FTSE 250

    20,170.96
    +118.63 (+0.59%)
     
  • AIM

    771.81
    +3.70 (+0.48%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.27%)
     
  • GBP/USD

    1.2559
    +0.0026 (+0.20%)
     
  • Bitcoin GBP

    49,051.44
    +1,761.40 (+3.72%)
     
  • CMC Crypto 200

    1,322.89
    +45.92 (+3.59%)
     
  • S&P 500

    5,120.54
    +56.34 (+1.11%)
     
  • DOW

    38,660.06
    +434.40 (+1.14%)
     
  • CRUDE OIL

    78.64
    -0.31 (-0.39%)
     
  • GOLD FUTURES

    2,302.90
    -6.70 (-0.29%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    17,995.44
    +98.94 (+0.55%)
     
  • CAC 40

    7,954.14
    +39.49 (+0.50%)
     

ANGLE Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag

ANGLE (LON:AGL) Full Year 2022 Results

Key Financial Results

  • Net loss: UK£21.7m (loss widened by 45% from FY 2021).

  • UK£0.088 loss per share (further deteriorated from UK£0.067 loss in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

ANGLE EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) exceeded analyst estimates by 2.3%.

Looking ahead, revenue is forecast to grow 50% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in the United Kingdom.

Performance of the British Medical Equipment industry.

ADVERTISEMENT

The company's shares are down 1.4% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 5 warning signs for ANGLE (1 can't be ignored) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here